297
Views
4
CrossRef citations to date
0
Altmetric
Research Article

8β-hydroxy-3-oxopimar-15-ene exerts anti-inflammatory effects by inhibiting ROS-mediated activation of the TRAF6-ASK1-p38 signaling pathway

, , , , , , , , , & show all
Pages 549-557 | Received 14 Mar 2013, Accepted 21 Jun 2013, Published online: 05 Aug 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Rana Dhar, Rungruedee Kimseng, Ratchanaporn Chokchaisiri, Poonsit Hiransai, Tanyarath Utaipan, Apichart Suksamrarn & Warangkana Chunglok. (2018) 2′,4-Dihydroxy-3′,4′,6′-trimethoxychalcone from Chromolaena odorata possesses anti-inflammatory effects via inhibition of NF-κB and p38 MAPK in lipopolysaccharide-activated RAW 264.7 macrophages. Immunopharmacology and Immunotoxicology 40:1, pages 43-51.
Read now

Articles from other publishers (3)

Samuel S. ValencaBrittany E. DongElizabeth M. GordonRamon C. Sun & Christopher M. Waters. (2022) ASK1 Regulates Bleomycin-induced Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology 66:5, pages 484-496.
Crossref
Wei Wang, Zhao Guo, Sidong Yang, Hui Wang & Wenyuan Ding. (2018) Upregulation of miR-199 attenuates TNF-α-induced Human nucleus pulposus cell apoptosis by downregulating MAP3K5. Biochemical and Biophysical Research Communications 505:3, pages 917-924.
Crossref
Alfredo Gragnani, Sarita Mac Cornick, Verônica Chominski, Samuel Marcos Ribeiro de Noronha, Silvana Aparecida Alves Corrêa de Noronha & Lydia Masako Ferreira. (2014) Review of Major Theories of Skin Aging. Advances in Aging Research 03:04, pages 265-284.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.